ANGI-09. δ-Catenin Regulates Bevacizumab-Induced Glioma Invasion

INTRODUCTION: Glioblastoma is one of the most aggressive intracranial neoplasms in humans. The addition of bevacizumab to the conventional standard therapy for newly diagnosed glioblastoma prolonged the progression-free survival time, but it failed to extend overall survival time. While bevacizumab...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Shimizu, Toshihiko, Kurozumi, Kazuhiko, Ishida, Joji, Oka, Tetsuo, Otani, Yoshihiro, Tomita, Yusuke, Hattori, Yasuhiko, Uneda, Atsuhito, Matsumoto, Yuji, Ichikawa, Tomotsugu, Date, Isao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692185/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.088
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia